Mar. 31, 2020
Comment on SEC Proposed Rule #S7-24-15: I understand the risks associated with holding these daily beta products for longer periods of time, their unique features, risks and fees. I actively monitor my L&I funds daily and, in most cases, throughout the day. I have contacted my brokerage firm and they agreed that I have been trading L&I funds for quite some time now and have signed their DI agreement. Without knowing what additional factors would go into my brokerage firm determining I am sufficiently capable or not capable to trade these products, I cannot fully agree they should have the right to decide for me. Fidelity Investment’s Trade Warning is as follows: TRADE WARNING (DI0103) This security is subject to the Designated Investments Agreement you previously signed for this account. Leveraged Products are intended for experienced, aggressive, sophisticated investors who actively manage their investments and who understand the risks and consequences of using leverage. Read the prospectus carefully to make sure that you understand their unique features, risks and fees. For more information on the risks of these securities, please place this order through Fidelity.com. I believe my prior use of L&I funds qualifies me to continue trading L&I funds under to proposed regulations. Thank you.